Metoclopramide Dosing Recommendations
The standard dose of metoclopramide is 10 mg administered orally or intravenously three to four times daily for nausea and vomiting, with a maximum daily dose of 30 mg and treatment duration limited to 5 days to minimize the risk of extrapyramidal disorders. 1, 2
Standard Dosing by Indication
Nausea and Vomiting (General)
- 10 mg orally or IV three to four times daily is the recommended dose for acute nausea and vomiting 1
- The dose may be administered slowly IV over 1-2 minutes 2
- Maximum daily dose should not exceed 30 mg/day 1
- Treatment duration should be limited to 5 days or less to reduce neurological risks 1
Diabetic Gastroparesis
- 10 mg administered 30 minutes before meals and at bedtime (four times daily) 1
- If severe symptoms are present, initiate therapy with IV or IM injection, then transition to oral administration once symptoms improve 2
- IV doses of 10 mg should be given slowly over 1-2 minutes 2
Chemotherapy-Induced Nausea and Vomiting
- Highly emetogenic chemotherapy (cisplatin, dacarbazine): 2 mg/kg IV per dose 2
- Less emetogenic regimens: 1 mg/kg IV per dose may be adequate 2
- Administer 30 minutes before chemotherapy, repeat every 2 hours for two doses, then every 3 hours for three doses 2
- IV infusions should be given slowly over at least 15 minutes 2
- For doses exceeding 10 mg, dilute in 50 mL of parenteral solution 2
Postoperative Nausea and Vomiting
Facilitating Small Bowel Intubation
- Adults and pediatric patients >14 years: 10 mg IV as a single dose 2
- Pediatric patients 6-14 years: 2.5-5 mg IV 2
- Pediatric patients <6 years: 0.1 mg/kg IV 2
Route Selection
IV Administration Preferred When:
- Severe nausea and vomiting requiring immediate relief 3
- Hospitalized patients with hyperemesis gravidarum not responding to first-line therapy 3
- Chemotherapy-induced emesis 2
- IV route provides faster onset of action and superior efficacy (84% pain relief at 1 hour vs 25% with oral) 3
Oral Administration Appropriate For:
- Outpatient management of less severe nausea and vomiting 3
- Maintenance therapy after initial IV treatment 2
- Gastroparesis in stable patients 1
Special Populations and Dose Adjustments
Renal Impairment
- Creatinine clearance <40 mL/min: Initiate therapy at approximately one-half the recommended dosage 2
- Adjust dose based on clinical efficacy and safety 2
Elderly Patients (>59 years)
- May require dose reduction due to higher risk of adverse effects 1
- Use the lowest effective dose and shortest duration possible 1
Pediatric Dosing for Chemotherapy
- Doses <2 mg/kg have minimal toxicity 4
- Doses ≥2 mg/kg associated with 15% extrapyramidal reactions and 33% akathisia 4
- Concomitant diphenhydramine recommended to reduce extrapyramidal reactions 4
Critical Safety Considerations
Maximum Dose and Duration Limits
- Never exceed 30 mg/day to minimize extrapyramidal disorders 1
- Limit treatment to ≤5 days to reduce risk of tardive dyskinesia 1
- These restrictions are based on European Medicines Agency safety recommendations 1
Contraindications and Cautions
- Avoid in patients with seizure disorders or pheochromocytoma 1
- Use with caution in GI bleeding or obstruction 1
- If acute dystonic reactions occur, administer 50 mg diphenhydramine IM immediately 2
Common Pitfalls to Avoid
- Do not use consecutive days of high-dose therapy in children without careful monitoring, as this increases extrapyramidal reaction risk 4
- Reserve metoclopramide for debilitating cases after other remedies have failed, as severe long-lasting adverse effects can occur even with low-dose, short-term use 5
- Long-lasting adverse effects (dizziness, anxiety, involuntary movements) have been reported lasting up to 10 months after only 30 mg total oral dose 5